Clinical significance of muscle layer interruption in T3 esophageal cancer

被引:0
作者
Sugimura, Keijiro [1 ]
Miyata, Hiroshi [1 ]
Yamasaki, Makoto [1 ]
Takahashi, Tsuyoshi [1 ]
Kurokawa, Yukinori [1 ]
Motoori, Masaaki [2 ]
Nakajima, Kiyokazu [1 ]
Takiguchi, Shuji [1 ]
Morii, Eiichi [3 ]
Yano, Masahiko [2 ]
Mori, Masaki [1 ]
Doki, Yuichiro [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Digest Surg, Higashinari Ku, Osaka 5378511, Japan
[3] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan
关键词
Muscle layer interruption; T3; Esophageal cancer; PLEURAL LAVAGE CYTOLOGY; SQUAMOUS-CELL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; TUMOR LENGTH; PROGNOSTIC-SIGNIFICANCE; INDUCTION CHEMOTHERAPY; MULTIMODAL TREATMENT; PHASE-II; DOCETAXEL; CISPLATIN;
D O I
10.1007/s10388-014-0420-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results Patients were classified as T1 (38.4 %), T2 (11.9 %), T3 (38.4 %), and T4 (11.2 %) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 %, p = 0.009). T3 tumors with < 20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 %), whereas those with a parts per thousand yen20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 %). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with a parts per thousand yen20 mm MLI than in those with < 20 mm MLI (4.3 vs. 21.4 %, p = 0.019). Conclusions T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with > 20 mm MLI.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 39 条
[1]   Dating the Rise of Esophageal Adenocarcinoma: Analysis of Connecticut Tumor Registry Data, 1940-2007 [J].
Abrams, Julian A. ;
Sharaiha, Reem Z. ;
Gonsalves, Lou ;
Lightdale, Charles J. ;
Neugut, Alfred I. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (01) :183-186
[2]   A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) [J].
Ando, Nobutoshi ;
Kato, Hoichi ;
Igaki, Hiroyasu ;
Shinoda, Masayuki ;
Ozawa, Soji ;
Shimizu, Hideaki ;
Nakamura, Tsutomu ;
Yabusaki, Hiroshi ;
Aoyama, Norio ;
Kurita, Akira ;
Ikeda, Kenichiro ;
Kanda, Tatsuo ;
Tsujinaka, Toshimasa ;
Nakamura, Kenichi ;
Fukuda, Haruhiko .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) :68-74
[3]   Impact of Radiotherapy, Chemotherapy and Surgery in Multimodal Treatment of Locally Advanced Esophageal Cancer [J].
Berger, Bernhard ;
Stahlberg, Katharina ;
Lemminger, Annina ;
Bleif, Martin ;
Belka, Claus ;
Bamberg, Michael .
ONCOLOGY, 2011, 81 (5-6) :387-394
[4]   Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial [J].
Burmeister, BH ;
Smithers, BM ;
Gebski, V ;
Fitzgerald, L ;
Simes, RJ ;
Devitt, P ;
Ackland, S ;
Gotley, DC ;
Joseph, D ;
Millar, J ;
North, J ;
Walpole, ET ;
Denham, JW .
LANCET ONCOLOGY, 2005, 6 (09) :659-668
[5]   The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging [J].
Chang, Eugene Y. ;
Li, Xin ;
Jerosch-Herold, Michael ;
Priest, Ryan A. ;
Enestvedt, C. Kristian ;
Xu, Jingang ;
Springer, Charles S., Jr. ;
Jobe, Blair A. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (01) :166-175
[6]   Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry [J].
Cummings, Linda C. ;
Cooper, Gregory S. .
CANCER DETECTION AND PREVENTION, 2008, 32 (01) :87-92
[7]  
Demeester Steven R, 2009, Gastrointest Cancer Res, V3, pS2
[8]   Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer? [J].
Doki, Y ;
Kabuto, T ;
Ishikawa, O ;
Ohigashi, H ;
Sasaki, Y ;
Yamada, T ;
Hiratsuka, M ;
Miyashiro, I ;
Kameyama, M ;
Murata, K ;
Imaoka, S ;
Yasuda, T ;
Nakaizumi, A ;
Takenaka, A .
SURGERY, 2001, 130 (05) :792-797
[9]  
Eisterer W, 2011, ANTICANCER RES, V31, P4407
[10]   Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus [J].
Endo, M ;
Yoshino, K ;
Kawano, T ;
Nagai, K ;
Inoue, H .
DISEASES OF THE ESOPHAGUS, 2000, 13 (02) :125-129